ArticleJournal of fluorescence2026
A Selective Fluorescent Probe with Pyridine-Imidazole Moiety for Detecting Glutathione in Pediatric Cellular Colorectal Injury.
Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
In this work, a selective fluorescent probe PIOr-GSH with pyridine-imidazole moiety was developed for detecting glutathione in pediatric cellular colorectal injury. Compared with the recent probes with the similar backbone, the modification of the hydroxyl position herein resulted in the enhancement of the signal intensity at 485 nm with the excitation of 310 nm. On the optical capabilities, the detecting system with PIOr-GSH exhibited the advantages including applicable linear range, high sensitivity, high steadiness in various working conditions (recognition time, pH, and incubation temperature). In particular, PIOr-GSH achieved the convenient and specific recognition towards GSH from the competing species including Cys/Hcy. As a challenging trial, PIOr-GSH achieved imaging the pediatric cellular colorectal injury status and the treatment efficacy by monitoring the intracellular GSH level. This work was meaningful for the rapid diagnosis and urgent therapeutics in the pediatric emergency.
Indexed as
Identifiers
40974483What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.